Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924651 · ClinicalTrials.gov registry record · NA
Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
A NA study, sponsored by Gary Morrow.
- Completed
- Registry status
- NA
- Development phase
- 693
- Enrollment target
NCT00924651 is a NA study that has completed, run by Gary Morrow. The registered enrollment target is 693 participants.
The verdict
NCT00924651, a NA study, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- NA
- Development phase
- 693 participants
- Enrollment target
Study Summary
RATIONALE: Physical activity may help lessen fatigue caused by cancer in patients receiving chemotherapy. It is not yet known whether a home-based walking and resistance-band exercise program is effective in lessening fatigue. PURPOSE: This randomized phase III trial is studying how well exercise works in lessening fatigue caused by cancer in patients undergoing chemotherapy.
Interventions
- BEHAVIORAL exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 693 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00924651
The ClinicalTrials.gov registry entry for NCT00924651 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 693 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gary Morrow, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which exercise is the first listed.
NCT00924651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00924651 about?
NCT00924651 is a clinical study titled "Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy". RATIONALE: Physical activity may help lessen fatigue caused by cancer in patients receiving chemotherapy. It is not yet known whether a home-based walking and resistance-band exercise program is effective in lessening fatigue. PURPOSE: This randomized phase III trial is studying how well exercise w...
What is the current status of trial NCT00924651?
This trial is currently completed. It is a NA study. The enrollment target is 693 participants. The study started on 2009-09. Estimated completion is 2016-10.
What interventions are being tested in trial NCT00924651?
The interventions under investigation include: exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT00924651?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.